A multimillionaire donates his organ; Kochouseph Chittilappilly, well known among entrepreneurs and the chairman and managing director of V-guard, recently came up with a novel idea to save the lives of people suffering from incurable kidney ailments. He has started a network of kidney donors and recipients called the Kidney Foundation of India. This new banking system reaches out to renal failure patients. Against the cases of kidney failure in Kerala the new kidney banking network has been started with these initiatives.
Aurolab: eye care Dr. Govindappa Venkataswamy founded Aravind Eye care Hospital in 1967. It has grown into a network of eye hospitals catering to millions of patients. The value …show more content…
It will still not work and it will receive mass rejection and no participation at all, unless we devise a strategy to convince them and explain them the big purpose. The convincing may gather some amount of participation, but mass participation will not be seen. So, what else is lacking? Here is where the power of marketing will do. What marketing does is, it studies the demographics, it understands what people need, it makes a product and makes people realize that they have this particular need. If there is no ‘need’ then Marketing develops a need. Balbir Pasha: an attempt to control spread of AIDS epidemic
The Balbir Pasha communication campaign to reduce HIV/AIDS resulted into increased tendency to discuss AIDS, increased number of people using preventive measures. PSI managed to deliver HIV/AIDS messages in an effective way. They directly spoke to target customer and did mass marketing through the fictional character Balbir Pasha.
In 1988, PSI began a small operation in India that has expanded into 22 states and union territories.
Current programs focus …show more content…
Start with the vastly increased supply of information. Over the last decade, pharmaceutical companies have been aggregating years of research and development data into medical databases, while payors and providers have digitized their patient records. Meanwhile, the US federal government and other public stakeholders have been opening their vast stores of health-care knowledge, including data from clinical trials and information on patients covered under public insurance programs. In parallel, recent technical advances have made it easier to collect and analyze information from multiple sources—a major benefit in health care, since data for a single patient may come from various payors, hospitals, laboratories, and physician